查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030 年全球血管移植市场
市场调查报告书
商品编码
1279682

2023-2030 年全球血管移植市场

Global Vascular Graft Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

全球血管移植物市场预计将以有利的速度增长，到 2022 年将达到 24.833 亿美元，到 2030 年将达到 44.04 亿美元。 预计血管移植市场在预测期内（2023-2030 年）的复合年增长率为 7.6%。

血管移植物是一种医疗器械，可在血管旁路治疗期间连接血管并引导血液从一个位置流向另一个位置。 在各种外科手术过程中，它有助于避免血管变窄，恢復受伤部位的血液流动，并避免心脏病发作和中风等问题。

心血管疾病发病率的增加、血管外科技术的进步、人口老龄化等预计将在预测期内促进全球血管移植市场的增长。

市场动态

预计透析手术数量的增加和慢性肾脏病 (CKD) 病例的增加将推动全球血管移植市场的增长。

全球透析手术数量的增加和慢性肾病 (CKD) 病例数量的增加正在推动全球血管移植市场的增长。 CKD 是一种退化性疾病，目前影响全球 8 亿多人。 例如，根据 2022 年发表在《肾臟国际增刊杂誌》上的一项研究，CKD 患病率上升将增加透析过程中对血管移植物的需求。

此外，美国肾臟基金会报告称，肾臟疾病影响了大约 3700 万美国人，而肾衰竭是美国十大死因之一，影响了大约 810,000 人。据说会导致 因此，由于上述因素，全球血管移植市场将在预测期内呈现增长。

全球血管移植物市场或面临血管□□移植物高成本的製约

血管移植物的高成本是全球血管移植物市场增长的主要製约因素。 血管移植物的价格根据所用材料的类型和手术的复杂程度而有所不同，例如，合成血管移植物往往比生物血管移植物便宜，但并不总是成功的。 因此，它是一种昂贵的产品，对于欠发达国家或没有保险的患者来说可能负担不起。

COVID-19 影响分析

由于业务运营、供应链、分销系统等方面的中断，COVID-19 爆发对血管移植物市场产生了负面影响。 其他择期手术已被取消或推迟，以帮助遏制冠状病毒的传播。 此外，由于医护人员专注于治疗 COVID-19，因此非必要手术有所减少。

俄乌衝突分析

全球血管移植物市场并没有受到俄罗斯和乌克兰衝突的特别影响。 儘管衝突造成了地缘政治动盪和经济制裁，但血管移植物的生产和分配在很大程度上不依赖于俄罗斯和乌克兰。 血管移植市场的大多数参与者都是在世界各地设有办事处和供应链的跨国公司。

血管移植物通常用于医疗目的，需求更多地是由患者需求和医疗保健法规驱动的，而不是地缘政治影响。 俄乌战争预计会对人工血管的可用性产生暂时和轻微的影响，但如果该地区的衝突和不稳定持续存在，包括人工血管市场在内的全球医疗保健部门将受到影响。它可以有行业产生广泛影响。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章定义和概述

第 3 章执行摘要

  • 按产品分类
  • 按原材料
  • 最终用户
  • 按地区

第四章市场动态

  • 影响因素
    • 主持人
      • 透析患者增加，慢性肾病 (CKD) 患者增加
    • 约束因素
      • 血管移植物的高成本
    • 机会
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 价格分析
  • 法律法规分析

第 6 章 COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情景
    • 当前的 COVID-19 情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格和动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章副产品

  • 血液透析通路移植物
  • 血管内动脉瘤修復覆膜支架
  • 外周血管移植

第 8 章按成分分类

  • 涤纶
  • 聚四氟乙烯 (PTFE)
  • 聚氨酯
  • 生物合成

第 9 章最终用户

  • 医院
  • 专科诊所
  • 门诊手术中心

第10章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第11章竞争格局

  • 竞争场景
  • 市场情况/份额分析
  • 併购分析

第12章公司简介

  • 雅培实验室
    • 公司简介
    • 产品组合和说明
    • 财务摘要
    • 主要发展状况
  • Braun Melsungen AG
  • Bard Peripheral Vascular Inc.（BD）
  • Cardinal Health（Cordis Corporation）
  • Cook Medical
  • Cryolife
  • Getinge Group
  • LeMaitre Vascular Inc
  • Medtronic PLC
  • W.L. Gore & Associates Inc

第13章 附录

简介目录
Product Code: MD747

Market Overview

The global vascular graft market reached US$ 2,483.3 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 4,404.0 million by 2030. The vascular graft market is expected to exhibit a CAGR of 7.6% during the forecast period (2023-2030).

Vascular grafts are medical devices that connect blood vessels during vascular bypass treatments to redirect blood flow from one location to another. They help to circumvent constrictions in blood arteries, restore blood flow to injured areas, and avoid problems like heart attacks and strokes during a variety of surgical operations.

The rising frequency of cardiovascular illnesses, technical improvements in vascular surgery, and the aging population are all expected to contribute to the global vascular graft market growth over the forecast period.

Market Dynamics

The Rising Number of Dialysis Procedures and a Rise in Cases of Chronic Kidney Disease (CKD) Are Expected to Drive the Global Vascular Graft Market Growth.

The growing number of dialysis procedures and a rise in cases of chronic kidney disease (CKD) worldwide are driving the growth of the global vascular graft market. CKD is a degenerative disease that now affects more than 800 million people worldwide. For instance, according to research that was published in the Journal Kidney International Supplements in 2022, the rising prevalence of CKD will increase the demand for vascular grafts in dialysis procedures.

Furthermore, according to the report by the American Kidney Fund, renal disease affects approximately 37 million Americans, and kidney failure, one of the top 10 leading causes of mortality in the country, affects around 810,000 people. Therefore, owing to the above factors, the global vascular graft market will witness growth over the forecast period.

The Global Vascular Graft Market May Face Constraints Due to High Cost of Vascular Grafts.

The high cost associated with the vascular graft is the major restraint for global vascular graft market growth. The vascular graft prices vary based on the kind of material used and how complicated the surgery is, for instance, synthetic grafts tend to be less expensive than biological ones, but they might not always be as successful. The products could not be affordable for patients in underdeveloped nations or for those without insurance because of their high price.

COVID-19 Impact Analysis

Due to the disruption in business operations, supply chains, distribution systems, etc., the COVID-19 outbreak had a negative effect on the market for vascular grafts. In order to stop the coronavirus from spreading, other elective procedures were either cancelled or put off. Additionally, because healthcare providers were concentrating on COVID-19 treatment, fewer non-essential surgeries were performed.

Russia Ukraine Conflict Analysis

The world market for vascular grafts has not been specifically impacted by the conflict between Russia and Ukraine. Although the conflict has caused geopolitical unrest and economic sanctions, the production and distribution of vascular grafts are not heavily reliant on either Russia or Ukraine. The majority of the top market participants for vascular grafts are multinational corporations with operations and supply networks dispersed around the globe.

Vascular grafts are mostly employed in medical treatments, and rather than being influenced by geopolitics, the demand for these devices is largely driven by patient demands and healthcare regulations. The Russia-Ukraine war is only anticipated to have a transient and small-scale impact on the availability of vascular grafts, , but any prolonged conflict or instability in the region could have wider implications for the global healthcare industry, including the vascular grafts market.

Segment Analysis

The global vascular graft market is segmented based on product, raw material, end user, and region.

The Hospitals Segment is Expected to Dominate the Global Vascular Graft Market.

The hospitals sgement dominated the global vascular graft market and accounted the highest vascular graft market share of 38.3%. Vascular grafting is one of the many surgical procedures that have become more common in hospitals as a result of the rising burden of chronic illnesses including cardiovascular disease and chronic renal disease. As a result, hospitals make up the majority of vascular transplant end users.

The expansion of the hospital end user sector is also being fueled by the availability of public and private insurance programmes for hospital treatments. Vascular graft surgeries can be obtained by patients through insurance plans, which increases their accessibility and affordability. Therefore, owing to the above factors, the hospiatals segment is likely to play major role in accelarating the global vascular graft market growth.

Geographical Analysis

North America Region Holds The Largest Market Share of the Global Vascular Graft Market.

The global vascular graft market is dominated by North America and holds 1/3rd market share, due to the high prevalence of diabetes, cardiovascular disease, and chronic kidney disease. The expansion of this market in North America is being fueled by the presence of reimbursement coverage and the accessibility of cutting-edge healthcare infrastructure. The expansion of biomaterials vascular grafts is sparked by ongoing technical advancements that are followed by the identification of particular goods made via tissue engineering.

Furthermore, the better reimbursement policies, cutting-edge technology, effective initiatives, and precise diagnostic processes using biometric instruments are some of the major contributors to the market's growth. Moreover, it is anticipated that ongoing research into the creation of advanced biomaterial grafts will increase demand for these products in the area.

Competitive Landscape

The major global players in the market include: Abbott Laboratories, Braun Melsungen AG, Bard Peripheral Vascular Inc., Cardinal Health (Cordis Corporation), Cook Medical, Cryolife, Getinge Group, LeMaitre Vascular Inc, Medtronic PLC, and W.L. Gore & Associates Inc.

Why Purchase the Report?

  • To visualize the global vascular graft market segmentation based on product, raw material, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global vascular graft market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global vascular graft market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Raw Material
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rising number of dialysis procedures and a rise in cases of chronic kidney disease (CKD)
    • 4.1.2. Restraints
      • 4.1.2.1. High cost of vascular grafts.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Hemodialysis Access Graft
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Endovascular Aneurysm Repair Stent Graft
  • 7.4. Peripheral Vascular Graft

8. By Raw Material

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
    • 8.1.2. Market Attractiveness Index, By Raw Material
  • 8.2. Polyester
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Polytetrafluoroethylene (PTFE)
  • 8.4. Polyurethane
  • 8.5. Biosynthetic

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Clinics
  • 9.4. Ambulatory Surgery Center

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Raw Material
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Abbott Laboratories*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Braun Melsungen AG
  • 12.3. Bard Peripheral Vascular Inc. (BD)
  • 12.4. Cardinal Health (Cordis Corporation)
  • 12.5. Cook Medical
  • 12.6. Cryolife
  • 12.7. Getinge Group
  • 12.8. LeMaitre Vascular Inc
  • 12.9. Medtronic PLC
  • 12.10. W.L. Gore & Associates Inc

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us